Optimising pharmaceutical laboratories: sustainability and efficiency
Meet the expert: Leon Blokker
We had the privilege of speaking with Leon Blokker, an expert from Haskoning who collaborates with the aforementioned pharmaceutical company. With his wealth of experience and insights, he shed light on the innovative strategies implemented to transform pharmaceutical laboratories into more efficient and sustainable spaces, drawing parallels with best practices in the manufacturing industry.Sustainability and innovation in action
The partnership's commitment to sustainability is genuinely remarkable. For instance, the pharmaceutical company is spearheading efforts to achieve net-zero carbon emissions by 2030. One significant project involves transforming a massive parking area into a solar panel park, producing renewable energy on a substantial scale. This initiative aligns with Belgium's regulations, which mandate a percentage of rooftops to be equipped with solar panels.
Blokker pointed out that the company's implementation of geothermal energy is particularly noteworthy. This involves creating their own geothermal sources for heating, a considerable investment that showcases their dedication to reducing carbon emissions.
BIM: a key to digital transformation
Blokker revealed that BIM is a primary tool used for digital transformation within their organisation. BIM, a technology that creates and manages digital representations of physical and functional characteristics of buildings, enables precise planning and execution of construction projects, much like the advancements seen in sustainable manufacturing.
The pharmaceutical industry's commitment to regulatory compliance and protocols showcases its dedication to safety and quality. While this conscientious approach can sometimes slow down the rapid integration of innovative technologies, it ensures that every step is taken thoughtfully and meticulously. This industry-wide dedication to adhering to best practices underscores the pharmaceutical sector's responsible approach to technology adoption and its commitment to maintaining high standards in all endeavours.
Challenges and triumphs in sustainability
Blokker candidly addressed the challenges of implementing sustainable practices within the pharmaceutical industry. He acknowledged the industry's cautious approach to adopting new technologies due to stringent regulations and the need for extensive documentation. Despite these hurdles, the partnership between Haskoning and the pharmaceutical company focuses on creating flexible environments that can accommodate changing requirements swiftly, much like the adaptability seen in the manufacturing industry.
Remaining ahead in the innovation game
Staying ahead in the ever-changing landscape of innovation is no small feat. Blokker shared that Haskoning achieves this by embracing flexibility in design and considering the latest technologies. Moreover, their experience and expertise allow them to be valuable partners in navigating the complexities of regulatory compliance.Beyond the partnership: other collaborations
While our discussion with Leon Blokker provided a comprehensive insight into the partnership between Haskoning and the pharmaceutical company, it's important to note that their expertise extends beyond this notable collaboration. They have engaged with other global pharmaceutical giants to build cutting-edge product facilities, incorporating sustainable manufacturing principles.Deep integration: the key to tailored solutions
One of the standout strengths of Haskoning is its ability to integrate with its clients' systems and operations seamlessly.
This deep integration goes beyond a mere contractual agreement; it's a true partnership that allows Haskoning to understand its client's unique challenges, goals, and operational intricacies.
